Target intelligence / Profile preview

Immunoglobulin G subclass 4 antibody (IgG4)

Target
IgG4
Molecular classification
Antibody, Immunoglobulin
01

Overview

Immunoglobulin G subclass 4 antibody (IgG4) is one of the four subclasses of immunoglobulin G found in human serum. It is produced by plasma B cells and represents a minor fraction of total serum IgG. Structurally, it consists of two γ heavy chains and two light chains (κ or λ), forming a Y-shaped molecule with antigen-binding sites at each arm. Unique among the subclasses, IgG4 exhibits functional monovalency due to its ability to undergo Fab-arm exchange—where half-molecules swap between antibodies—resulting in bispecific antibodies that can bind two different antigens. This property makes it generally immunologically inert, as it does not efficiently activate complement or trigger immune effector functions through Fcγ receptors. Biologically, IgG4 plays a role in modulating immune responses, often associated with chronic antigen exposure and tolerance rather than acute inflammation. Elevated levels are characteristic of certain autoimmune conditions collectively termed "IgG4-related diseases," which include disorders such as autoimmune pancreatitis and sclerosing cholangitis. Measurement of serum IgG4 serves as a biomarker for these diseases. While therapies affecting B cell activity more broadly can influence overall immunoglobulin production patterns, IgG4 is not considered a direct therapeutic target like a receptor or enzyme. The term "Immunoglobulin G subclass 4 antibody" (abbreviation: IgG4) describes a specific molecular entity.

Other names
IgG4Immunoglobulin G4IgG subclass 4
02

Biological functions

Immune response modulationAntigen binding
03

Disease associations

Autoimmune disease (e.g., IgG4-related disease)Inflammation
04

Safety considerations

Potential for involvement in autoimmune pathology (IgG4-related disease)
05

Biomarkers

Serum IgG4 level (for diagnosis and monitoring of IgG4-related disease)

Beyond the preview

Go deeper on Immunoglobulin G subclass 4 antibody (IgG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin G subclass 4 antibody (IgG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call